Skip to content

Cambodia Integrated HIV and Drug Prevention Implementation Program

Cambodia Integrated HIV and Drug Prevention Implementation Program

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01835574
Acronym
CIPI
Enrollment
1198
Registered
2013-04-19
Start date
2013-04-30
Completion date
2016-12-31
Last updated
2017-05-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

HIV

Keywords

Amphetamine-type substance use

Brief summary

HIV risk among female entertainment and sex workers (FESW) remains high and use of amphetamine-type stimulants (ATS) significantly increases this risk. We designed a cluster randomized stepped wedge trial: The Cambodia Integrated HIV and Drug Prevention Implementation \[CIPI) study. The CIPI study is embedded within the SMARTgirl HIV prevention program. The CIPI study aimed to recruit FESW from 10 provinces, assessing HIV risk exposures including ATS use. The CIPI study then tested sequentially delivered, behavioral interventions targeting ATS use. The trial combines a 12-week Conditional Cash Transfer (CCT) intervention with four-weeks of cognitive-behavioral group aftercare (AC) among FESW who use ATS. The primary goal of the CIPI study is to reduce ATS use and unprotected sex among FESW. The CCT+AC intervention is being implemented in ten provinces where order of delivery was randomized. Outcome assessments (OEs) including biomarkers and self-reported measures of recent sexual and ATS use behaviors are conducted prior to implementation, and at three 6-month intervals after completion. All women who are ATS negative at 6-months, including those who have completed the CCT+AC intervention are eligible to participate in a micro-enterprise (ME) opportunity. Consultation with multiple groups and stakeholders on implementation factors facilitated acceptance and operationalization of the trial. Statistical power and sample size calculations were based on expected changes in ATS use and unprotected sex at the population level as well as within-subjects. Dissemination of process indicators during the multi-year trial is carried out through annual in-country Stakeholder Meetings. Provincial 'Close-Out' forums are held at the conclusion of data collection in each province. When analysis is completed, dissemination meetings will be held in Cambodia with stakeholders, including community-based discussions sessions, policy briefs, and results published and presented in the HIV prevention scientific journals and conferences. CIPI is the first trial of an intervention to reduce ATS use and HIV risk among FESW in Cambodia. Results will inform both CCT+AC implementation in low and middle-income countries and programs designed to reach FESW.

Detailed description

The CIPI Study is 16-week program that combines Conditional Cash Transfer (CCT) and group-based supportive After Care (AC) for moderate and high risk FESW ATS users using a stepped wedge randomized cluster design. The trial tests the CCT+AC intervention in 10 Cambodian provinces (clusters). Outcome Evaluation (OE) data is collected at 1 time-point prior to implementation of the CCT+AC program (Baseline), and 3 time-points after the intervention (OE-1, OE-2, and Post-OE) at 6, 12, and 18 months after baseline in each province. CCT+AC is followed by a linked economic capacity building opportunity. Women who are ATS-free, including those negative at baseline and those who successfully complete the CCT+AC intervention are eligible for referral to a MicroEnterprise (ME) program. The ME program combines financial literacy education and referral to a Cambodian registered microfinance organization (Chamroeun) for loan applications that may support alternate economic options for participating eligible women.

Interventions

BEHAVIORALConditional cash transfer and cognitive-behavioral aftercare

The intervention combines a 12-week conditional cash transfer (CCT) intervention with 4-weeks of cognitive-behavioral group aftercare (AC) among women who use ATS. CCT includes thrice weekly urine screening for 12 weeks; participants receive $ for ATS-negative screens. Those with 3 negative screens in a week participants receive a cash bonus, which increase per month to mitigate habituation to the CCT reward schedule. Women who complete \>=50% of ATS negative screening visits may participate in a 4-week, cognitive-behavioral AC group delivered immediately after CCT, which includes: 1) experiential group exercises; 2) didactic recovery skills training; 3) meditation and relaxation training; and 4) a ''lucky draw'' which is a form of CCT that provides positive reinforcement for group attendance.

Sponsors

University of California, San Francisco
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* 18 years of age or older * biological female * speaks Khmer language * self reports 2 or more sex partners and/or transactional sex in last month * able to provide informed consent

Exclusion criteria

* male sex * under 18 years of age * unable to speak Khmer language * unable to consent

Design outcomes

Primary

MeasureTime frameDescription
Sexual risk6, 12 and 18 monthsChange in number of sexual partners in the past 3 months (measured as a numeric variable).
Amphetamine type stimulant use (ATS)6, 12, and 18 monthsChange in ATS use as measured by urine toxicology screening.

Secondary

MeasureTime frameDescription
Sexual risk 36, 12 and 18 monthsBiomarker outcome (prostate specific antigen (PSA)) indicating unprotected vaginal sex Biomarker outcome (prostate specific antigen (PSA)) indicating unprotected vaginal sex
Sexual risk 26,12, and 18 monthsNumber of new sexual partners in the past 3 months.
Sexual risk 46,12, and 18 monthsCondom use with all paying partners
Sexual risk 56,12, and 18 monthsCondom use with all non-paying partners
ATS 26,12 and 18 monthsSelf-reported ATS use using ASSIST
ATS 36, 12, and 18 monthsSelf-reported binge use of ATS

Other

MeasureTime frameDescription
HIV and STI service use6, 12 and 18 monthsHIV testing and STI diagnoses
Reproductive health outcomes6, 12 and 18 months(i) visits to reproductive health clinics, (ii) birth control use, (iii) pregnancy termination
Economic well being6,12, and 18 months(i) income, (ii) housing instability, (iii) food insecurity, (iv) number of electronic devices in the home
Psychological distress6, 12, and 18 monthsKessler 10 scale score
Hazardous drinking6, 12, and 18 monthsSelf-reported alcohol use as measured by AUDIT-C
Recent alcohol use6, 12, and 18 monthsSelf-reported alcohol use as measured by ASSIST

Countries

Cambodia

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 1, 2026